Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The progestogen-only mini-pill.

S Graham, I S Fraser

    Contraception
    |October 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Research and clinical management for women with abnormal uterine bleeding in the reproductive years: More than PALM-COEIN.

    BJOG : an international journal of obstetrics and gynaecology·2016
    Same author

    Inflammation and endometrial bleeding.

    Climacteric : the journal of the International Menopause Society·2014
    Same author

    Dysregulation of vascular endothelial growth factors and their neuropilin receptors in the eutopic endometrium of women with endometriosis.

    Reproductive sciences (Thousand Oaks, Calif.)·2013
    Same author

    Iatrogenic unscheduled (breakthrough) endometrial bleeding.

    Reviews in endocrine & metabolic disorders·2012
    Same author

    Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.

    Human reproduction (Oxford, England)·2011
    Same author

    Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis.

    Reproductive sciences (Thousand Oaks, Calif.)·2011
    Same journal

    Reasons patients decide to replace or extend their long-acting reversible contraceptive before the full duration of pregnancy prevention: a qualitative study.

    Contraception·2026
    Same journal

    Awareness of abortion medications by mail options among abortion patients at 6 clinics: Findings from a pilot study.

    Contraception·2026
    Same journal

    A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injection.

    Contraception·2026
    Same journal

    Associations between pharmacy type, neighborhood disadvantage, and availability and accessibility of an over-the-counter oral contraceptive pill in three Michigan counties.

    Contraception·2026
    Same journal

    Previous caesarean section and major complications during surgical abortion: a national multicentre case-control study.

    Contraception·2026
    Same journal

    Quantification of residual levonorgestrel following extended use of the levonorgestrel 52 mg intrauterine device beyond 8 years.

    Contraception·2026
    See all related articles

    The progestogen-only mini-pill is an under-used contraceptive due to low awareness among medical providers. This review highlights its efficacy and minor side effects, recommending wider adoption.

    Area of Science:

    • Reproductive Health
    • Contraception
    • Pharmacology

    Background:

    • The progestogen-only contraceptive "mini-pill" is significantly under-utilized.
    • Lack of awareness among healthcare providers contributes to its limited use.

    Purpose of the Study:

    • To review existing literature on the progestogen-only mini-pill.
    • To evaluate the benefits and disadvantages of this contraceptive method.
    • To provide recommendations for increased utilization.

    Main Methods:

    • Literature review of scientific publications.
    • Analysis of efficacy and side effect profiles.
    • Evaluation of clinical benefits and drawbacks.

    Main Results:

    Keywords:
    BleedingContraceptionContraception ContinuationContraception Failure--statisticsContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, Female--side effectsContraceptive Agents, ProgestinContraceptive Agents--side effectsContraceptive MethodsContraceptive Methods--pharmacodynamicsContraceptive UsageDiseasesFamily PlanningLevonorgestrelOral Contraceptives, Low-doseOral Contraceptives--pharmacodynamicsPregnancy, EctopicProgestins, Low-dose--side effectsSigns And Symptoms

    Related Experiment Videos

    • The progestogen-only mini-pill demonstrates reasonable contraceptive efficacy.
    • Reported side effects are generally minor.
    • Under-use is linked to insufficient provider knowledge.

    Conclusions:

    • The progestogen-only mini-pill is an effective and safe contraceptive option.
    • Increased provider education is crucial for promoting its wider use.
    • Recommendations are provided to enhance mini-pill adoption in clinical practice.